NEW YORK (GenomeWeb News) – Genetic Technologies today said that New York has issued a Clinical Laboratory Permit to the firm, allowing GTG to offer its BREVAGen test to residents of the state.

The permit completes the out-of-state licensures needed, and GTG can offer the breast cancer test to all 50 states in the US. GTG received CLIA certification of compliance for its Australian lab in February 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.